Northern Trust’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-880
Closed -$13K 4742
2021
Q2
$13K Sell
880
-612
-41% -$10.2K ﹤0.01% 4552
2021
Q1
$28K Sell
1,492
-17
-1% -$409 ﹤0.01% 4424
2020
Q4
$29K Sell
1,509
-44
-3% -$728 ﹤0.01% 4292
2020
Q3
$16K Sell
1,553
-239
-13% -$2.77K ﹤0.01% 4236
2020
Q2
$20K Sell
1,792
-120
-6% -$915 ﹤0.01% 4170
2020
Q1
$11K Sell
1,912
-92
-5% -$482 ﹤0.01% 4145
2019
Q4
$10K Sell
2,004
-12
-0.6% -$57 ﹤0.01% 4197
2019
Q3
$12K Buy
2,016
+2
+0.1% +$17 ﹤0.01% 4184
2019
Q2
$19K Buy
2,014
+23
+1% +$274 ﹤0.01% 4174
2019
Q1
$28K Sell
1,991
-42
-2% -$577 ﹤0.01% 4098
2018
Q4
$23K Sell
2,033
-42
-2% -$648 ﹤0.01% 4138
2018
Q3
$41K Buy
2,075
+244
+13% +$5.3K ﹤0.01% 4158
2018
Q2
$46K Buy
+1,831
New +$44K ﹤0.01% 4131
2016
Q3
Sell
-3,780
Closed -$214K 4209
2016
Q2
$214K Sell
3,780
-10
-0.3% -$564 ﹤0.01% 3704
2016
Q1
$217K Buy
+3,790
New +$201K ﹤0.01% 3702
2015
Q4
Sell
-57,793
Closed -$3.31M 4318
2015
Q3
$3.31M Buy
57,793
+770
+1% +$62K ﹤0.01% 2729
2015
Q2
$5.15M Buy
57,023
+1,205
+2% +$104K ﹤0.01% 2498
2015
Q1
$5.37M Buy
55,818
+13,544
+32% +$1.25M ﹤0.01% 2465
2014
Q4
$3.7M Sell
42,274
-1,255
-3% -$108K ﹤0.01% 2686
2014
Q3
$3.98M Buy
43,529
+41,517
+2,063% +$4.5M ﹤0.01% 2662
2014
Q2
$232K Sell
2,012
-24,488
-92% -$2.9M ﹤0.01% 3818
2014
Q1
$3.21M Buy
+26,500
New +$3.47M ﹤0.01% 2845

Other funds holding TRIB

Northern Trust's TRIB Position: Q3 2021 in Review

Northern Trust sold out of Trinity Biotech (TRIB) in Q3 2021, closing a stake of 880 shares — an estimated $13K sold.

Northern Trust first reported a position in TRIB in Q1 2014 and held it in 22 quarters. The position peaked at $5.37M in Q1 2015. 22 funds tracked by Wall St. Rank hold TRIB as of Q3 2021.

  • Northern Trust reported no remaining Trinity Biotech position as of Q3 2021 after selling out during the quarter.
  • Northern Trust sold 880 Trinity Biotech shares in Q3 2021, an estimated $13K.
  • Northern Trust first reported a position in Trinity Biotech in Q1 2014 and held it in 22 quarters.
  • Northern Trust's Trinity Biotech position peaked at $5.37M in Q1 2015.
  • 22 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2021.

Based on Northern Trust's 13F filing for Q3 2021, filed 15 Nov 2021.